Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/17/25 17:53 | 10/15/25 | KROS | Health | Drug | Pharmaceutical Preparations | Pontifax Management 4 G.P. (2015) Ltd. | L3 | T | 1 | S | -84,975 | 17.75 | 0 | -4,787 | -100 | 11 | I | |||||||||||||||
10/15/25 13:24 | 10/15/25 | KROS | Health | Drug | Pharmaceutical Preparations | Adar1 Capital Management, LLC | TX | T | 1 | S | -95,659 | 17.75 | 0 | -5,389 | -100 | 0 | I | |||||||||||||||
1/24/25 16:15 | 1/4/24 | KROS | Health | Drug | Pharmaceutical Preparations | Regnante Keith | MA | O | CFO | 1 | S.a | -1,812 | 45.29 | 0 | -40 | -100 | 0 | D | ||||||||||||||
8/15/24 17:06 | 8/13/24 | KROS | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | MA | D | 1 | S | -11,003 | 44.01 | 0 | -250 | 120 | I | ||||||||||||||||
8/15/24 17:01 | 8/13/24 | KROS | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | D | 1 | S | -11,003 | 44.01 | 0 | -250 | 120 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |